BACKGROUND: Statins inhibit 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, a key rate-limiting enzyme in the mevalonate pathway. Accumulating data suggest that statins exhibit anti-inflammatory effects on a number of experimental models including experimental autoimmune encephalomyelitis and antigen-induced allergic airway inflammation. However, the mechanism underlying the anti-inflammatory effect of statins is still largely unknown. In this study, we examined the effect of a representative statin, simvastatin, on proinflammatory cytokine production from murine mast cells. METHODS: Bone marrow-derived mast cells (BMMCs) were stimulated with lipopolysaccharide (LPS) in the presence or absence of simvastatin, and TNF-alpha and IL-6 production from BMMCs was evaluated at mRNA and protein levels. The effect of simvastatin on the expression of tristetraprolin, an RNA-binding protein that promotes decay of TNF-alpha mRNA, was evaluated. RESULTS: Incubation of BMMCs with simvastatin resulted in the inhibition of LPS-induced TNF-alpha production at both mRNA and protein levels. Simvastatin also inhibited IL-6 production from LPS-stimulated BMMCs. However, simvastatin did not enhance the expression of tristetraprolin. CONCLUSIONS: Simvastatin inhibits the production of TNF-alpha and IL-6 from activated mast cells in part by inhibiting de novo synthesis of their transcripts and the inhibition may account for the anti-inflammatory effect of simvastatin. Copyright 2008 S. Karger AG, Basel.
BACKGROUND: Statins inhibit 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, a key rate-limiting enzyme in the mevalonate pathway. Accumulating data suggest that statins exhibit anti-inflammatory effects on a number of experimental models including experimental autoimmune encephalomyelitis and antigen-induced allergic airway inflammation. However, the mechanism underlying the anti-inflammatory effect of statins is still largely unknown. In this study, we examined the effect of a representative statin, simvastatin, on proinflammatory cytokine production from murine mast cells. METHODS: Bone marrow-derived mast cells (BMMCs) were stimulated with lipopolysaccharide (LPS) in the presence or absence of simvastatin, and TNF-alpha and IL-6 production from BMMCs was evaluated at mRNA and protein levels. The effect of simvastatin on the expression of tristetraprolin, an RNA-binding protein that promotes decay of TNF-alpha mRNA, was evaluated. RESULTS: Incubation of BMMCs with simvastatin resulted in the inhibition of LPS-induced TNF-alpha production at both mRNA and protein levels. Simvastatin also inhibited IL-6 production from LPS-stimulated BMMCs. However, simvastatin did not enhance the expression of tristetraprolin. CONCLUSIONS:Simvastatin inhibits the production of TNF-alpha and IL-6 from activated mast cells in part by inhibiting de novo synthesis of their transcripts and the inhibition may account for the anti-inflammatory effect of simvastatin. Copyright 2008 S. Karger AG, Basel.
Authors: Diana G Soares; Zhanpeng Zhang; Fatma Mohamed; Thomas W Eyster; Carlos A de Souza Costa; Peter X Ma Journal: Acta Biomater Date: 2017-12-30 Impact factor: 8.947
Authors: Behzad Yeganeh; Emilia Wiechec; Sudharsana R Ande; Pawan Sharma; Adel Rezaei Moghadam; Martin Post; Darren H Freed; Mohammad Hashemi; Shahla Shojaei; Amir A Zeki; Saeid Ghavami Journal: Pharmacol Ther Date: 2014-02-26 Impact factor: 12.310
Authors: Maryam Montazerolghaem; Yi Ning; Håkan Engqvist; Marjam Karlsson Ott; Maria Tenje; Gemma Mestres Journal: J Mater Sci Mater Med Date: 2015-12-24 Impact factor: 3.896
Authors: Hilda J I De Jong; Jan G M C Damoiseaux; Rob J Vandebriel; Patrick C Souverein; Eric R Gremmer; Mia Wolfs; Olaf H Klungel; Henk Van Loveren; Jan Willem Cohen Tervaert; W M Monique Verschuren Journal: PLoS One Date: 2013-10-16 Impact factor: 3.240
Authors: Julie R Jin; Elena Gogvadze; Ana R Xavier; Thomas Bohnacker; Jan Voelzmann; Matthias P Wymann Journal: Front Immunol Date: 2020-10-28 Impact factor: 7.561